![]() |
|
|
Vol. 299, Issue 1, 261-267, October 2001
Department of Pharmacy, Kyoto University Hospital, Kyoto
University, Kyoto, Japan (A.T., S.M., H.S., K.I.); and Department of
Neurophysiology, Tohoku University School of Medicine, Sendai, Japan
(T.A.)
We characterized the interactions of various compounds with OAT-K1 and
OAT-K2, kidney-specific organic anion transporters. By using
Madin-Darby canine kidney cells stably transfected with OAT-K1 or
OAT-K2 cDNA, the antitumor drug methotrexate, the mycotoxin ochratoxin
A, endogenous organic anions (thyroid hormones, taurocholic acid, and
conjugated steroids), and the antiretroviral drug zidovudine were shown
to be substrates for these transporters. Although the apparent
Michaelis constant (Km) values of
methotrexate for OAT-K1 and OAT-K2 were 2.1 and 1.8 µM, respectively,
2.5 mM methotrexate inhibited only 20% of the 125I-thyroid
hormones uptake via these transporters. In addition, 100 µM
methotrexate did not have any effect on [3H]zidovudine
uptake via OAT-K1 or OAT-K2. Similarly, several substrates caused
little or no mutual inhibition at concentrations much higher than their
Km values for these transporters. Moreover,
intracellular methotrexate trans-stimulated the OAT-K1-
and OAT-K2-mediated uptake of [3H]folic acid, but not
that of other compounds. Organic anion-transporting polypeptide 2 (oatp2), a liver-type homolog of OAT-K1 and OAT-K2, showed similar
events. The inhibition constant values of triiodothyronine and
taurocholic acid for [3H]digoxin uptake in
oatp2-expressing oocytes resulted in 50.4 and 1.48 mM, respectively,
which were about 9- and 40-fold higher than their
Km values for oatp2, respectively. These
findings suggested that several substrates interact with these
transporters at different amino acid residue(s). Taken together, these
observations suggested that OAT-K1 and OAT-K2 could serve as
multispecific transporters, mediating transport of a wide variety of
endogenous substances, xenobiotics, and their metabolites in the
kidney, presumably via several interaction sites in their molecules.
This article has been cited by other articles:
![]() |
H. Yamaguchi, M. Okada, S. Akitaya, H. Ohara, T. Mikkaichi, H. Ishikawa, M. Sato, M. Matsuura, T. Saga, M. Unno, et al. Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3 J. Lipid Res., June 1, 2006; 47(6): 1196 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marin-Kuan, S. Nestler, C. Verguet, C. Bezencon, D. Piguet, R. Mansourian, J. Holzwarth, M. Grigorov, T. Delatour, P. Mantle, et al. A Toxicogenomics Approach to Identify New Plausible Epigenetic Mechanisms of Ochratoxin A Carcinogenicity in Rat Toxicol. Sci., January 1, 2006; 89(1): 120 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mikkaichi, T. Suzuki, T. Onogawa, M. Tanemoto, H. Mizutamari, M. Okada, T. Chaki, S. Masuda, T. Tokui, N. Eto, et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney PNAS, March 9, 2004; 101(10): 3569 - 3574. [Abstract] [Full Text] [PDF] |
||||